Can clinicians now assure their breast cancer patients that soyfoods are safe?

Women's Health

Volumn 6, Issue 3, 2010, Pages 335-338

  Messina, Mark ^a   Abrams, Donald I ^b   Hardy, Mary ^c  

^a LOMA LINDA UNIVERSITY   (United States)

^b Osher Center for Integrative Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; GENISTEIN; ISOFLAVONE DERIVATIVE; TAMOXIFEN;

BREAST CANCER; CANCER INHIBITION; CANCER PATIENT; DRUG EFFICACY; EDITORIAL; FOOD INTAKE; FOOD SAFETY; HUMAN; NONHUMAN; PHYSICIAN ATTITUDE; PROGNOSIS; SOYBEAN; SOYBEAN MILK;

BREAST NEOPLASMS; DIET; FEMALE; HUMANS; ISOFLAVONES; PHYSICIANS; SOY FOODS;

EID: 77952165063     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.10.20     Document Type: Editorial

References (37)

1. Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 81, 397-408 (2005).
2. Shu XO, Zheng Y, Cai H et al.: Soy food intake and breast cancer survival. JAMA 302, 2437-2443 (2009). •• Large Chinese prospective epidemiologic study demonstrating that soyfood consumption after diagnosis improves the prognosis of estrogen receptor-positive breast cancer patients and does not interfere with the efficacy of tamoxifen.
3. United Soybean Board: 16th Annual: Consumer Attitudes About Nutrition. United Soybean Board, MO, USA (2009).
4. Messina M, Lane B: Soy protein, soybean isoflavones, and coronary heart disease risk: where do we stand? Future Lipidol. 2, 55-74 (2007).
5. Koh WP, Wu AH, Wang R et al.: Gender-specific associations between soy and risk of hip fracture in the Singapore Chinese Health Study. Am. J. Epidemiol. 170, 901-909 (2009).
6. Zhang X, Shu XO, Li H et al.: Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch. Intern. Med. 165, 1890-1895 (2005).
7. Howes LG, Howes JB, Knight DC: Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 55, 203-211 (2006).
8. Franke AA, Custer LJ, Wang W, Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med. 217, 263-273 (1998).
9. Messina M, Nagata C, Wu AH: Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 55, 1-12 (2006).
10. Folman Y, Pope GS: The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other uterovaginotrophic compounds of low potency. J. Endocrinol. 34, 215-225 (1966).
11. 3H]oestradiol by uterus, vagina and skeletal muscle of immature mice. J. Endocrinol. 44, 213-218 (1969).
12. Kuiper GG, Lemmen JG, Carlsson B et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263 (1998).
13. Kostelac D, Rechkemmer G, Briviba K: Phytoestrogens modulate binding response of estrogen receptors α and β to the estrogen response element. J. Agric. Food Chem. 51, 7632-7635 (2003).
14. Oseni T, Patel R, Pyle J, Jordan VC: Selective estrogen receptor modulators and phytoestrogens. Planta Med. 74, 1656-1665 (2008).
15. Akiyama T, Ishida J, Nakagawa S et al.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595 (1987).
16. Sarkar FH, Li Y: Soy isoflavones and cancer prevention. Cancer Invest. 21, 744-757 (2003).
17. Banerjee S, Li Y, Wang Z, Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett. 269, 226-242 (2008).
18. Hsieh CY, Santell RC, Haslam SZ, Helferich WG: Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58, 3833-3838 (1998).
19. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG: Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131, 2957-2962 (2001).
20. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG: Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22, 1667-1673 (2001).
21. Helferich WG, Andrade JE, Hoagland MS: Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 16, 219-226 (2008). • Comprehensive review article that discusses the in vitro and rodent work underlying the basis for concern that soybean isoflavone exposure is contraindicated for breast cancer patients.
22. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG: Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27, 856-863 (2006).
23. Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG: Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res. 62, 2474-2477 (2002).
24. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG: Dietary genistein negates the inhibitory effect of letrozole on the growth of aromataseexpressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 29 (11), 2162-2168 (2008).
25. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG: Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649-1657 (2004).
26. Allred CD, Twaddle NC, Allred KF et al.: Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice. J. Agric. Food Chem. 53, 8542-8550 (2005).
27. Kang X, Jin S, Zhang Q: Antitumor and antiangiogenic activity of soy phytoestrogen on 7, 12-dimethylbenz[α] anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats. J. Food Sci. 74, H237-H242 (2009).
28. Boyapati SM, Shu XO, Ruan ZX et al.: Soyfood intake and breast cancer survival: a follow up of the Shanghai Breast Cancer Study. Breast Cancer Res. Treat. 92, 11-17 (2005).
29. Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ: Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res. Treat. 118, 395-405 (2009).
30. Hooper L, Ryder JJ, Kurzer MS et al.: Effects of soy protein and isoflavones on circulating hormone concentrations in pre-and post-menopausal women: a systematic review and meta-analysis. Hum. Reprod. Update 15, 423-440 (2009).
31. Conner P, Skoog L, Soderqvist G: Breast epithelial proliferation in postmenopausal women evaluated through fine-needleaspiration cytology. Climacteric 4, 7-12 (2001).
32. Conner P, Soderqvist G, Skoog L et al.: Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res. Treat. 78, 159-165 (2003).
33. Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens. Climacteric 4, 42-48 (2001).
34. Messina MJ, Wood CE: Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr. J. 7, 17 (2008). •• Comprehensive review article that critically evaluates the concern that isoflavone exposure is contraindicated for breast cancer patients with an emphasis on the clinical data, which demonstrate that neither isoflavone supplements nor soyfoods adversely affect markers of breast cancer risk.
35. Maskarinec G, Verheus M, Tice JA: Epidemiologic studies of isoflavones and mammographic density Nutrients 2, 35-48 (2010). • Comprehensive evaluation of the clinical and epidemiologic literature that demonstrates that isoflavone exposure does not affect mammographic breast density.
36. Ballard-Barbash R, Neuhouser ML: Challenges in design and interpretation of observational research on health behaviors and cancer survival. JAMA 302, 2483-2484 (2009).
37. Doyle C, Kushi LH, Byers T et al.: Nutrition and physical activity during and after cancer treatment: an american cancer society guide for informed choices. CA Cancer J. Clin. 56, 323-353 (2006).